Table 2.
Reference | Study Design | Sample Size | Subject Country of Origin | Sample Type | Sequencing Methods | Outcomes | Major Findings |
---|---|---|---|---|---|---|---|
Dicksved18 | Case-control | 10 GC patients, 5 dyspeptic controls | Sweden | Gastric biopsies from antrum and corpus | T-RLFP, 16S rRNA gene sequencing | Microbial composition of GC patients compared to controls | No significant difference between microbial composition of gastric cancer patients compared to controls |
Wang19 | Case-control | 103 GC patients, 212 chronic gastritis controls | China | Gastric biopsies from antrum or within 5 cm of cancerous lesion | 16S rRNA pyrosequencing | Bacterial load of gastric mucosa; Biodiversity, composition, structure of microbiota | ↑ Bacterial load in GC patients ↑ Lactobacillus, Escherichia-Shigella, Nitrospirae, Burkholderia fungorum in GC patients No significant difference in diversity index between GC and chronic gastritis |
Aviles-jimenez20 | Case-control | 5 GC patients, 5 IM patients, 5 nonatrophic gastritis patients | Mexico | Gastric biopsies from antrum in non-cancer patients, biopsies from lesion in GC patients | G3 PhyloChip 16S rRNA microarray | Gastric microbiota diversity; Taxa abundance differences between groups | ↓ bacterial diversity in GC patients compared to IM and gastritis patients ↑ Lactobacillus coleohominis and Lachnospiraceae in GC patients |
Coker21 | Case-control | 20 GC, 17 IM, 23 AG, 21 superficial gastritis patients | China | Gastric biopsies from antrum, body, fundus for non-cancer patients; Biopsies from lesion in GC patients | 16s rRNA gene sequencing via Mothur software | Microbial diversity and richness | ↓ bacterial diversity and richness in GC and IM patients compared to AG and superficial gastritis Overrepresentation of oral flora in GC, particularly P. stomatis, S. exigua, P. micra, S. anginosus and D. pneumosintes |
Ferreira22 | Case-control | 54 GC, 81 chronic gastritis patients | Portugal | Gastric biopsies or surgical specimens (non-neoplastic tissue adjacent to tumor only) | 16S rRNA next generation sequencing via ION PGM | Gastric microbial diversity | ↓ gastric microbial diversity in GC ↓ H. pylori abundance in GC ↑ presence of bacteria with nitrate reductase and nitrite reductase functions |
Eun23 | Case-control | 11 GC, 10 IM, 10 chronic gastritis patients | Korea | Gastric biopsies from antrum and corpus (non-neoplastic tissue adjacent to tumor only) | 16S rRNA gene sequencing using high throughput sequencing platform, 454 GS FLX Titanium | Diversity of gastric microbiota | ↑ microbial diversity in GC group compared to IM and gastritis ↑ abundance of Streptococcus, Lactobacillus, Veillonella, and Prevotella in GC |
Castaño-Rodriguez24 | Case-control | 12 GC, 20 functional dyspepsia patients | Singapore and Malaysia | Gastric biopsies from antrum | 16S rRNA gene sequencing using Illumina MiSeq | Gastric microbiota richness and phylogenetic diversity | ↑ microbial richness and phylogenetic diversity in GC patients ↑ Lactococcus, Lactobacillus, Veilonella, and Fusobacteriaceae taxa in GC patients |
Hu25 | Case-control | 6 GC, 5 chronic gastritis patients | China | Gastric wash samples | Shotgun metagenomic sequencing | Gastric microbiota richness and relative bacterial abundance | ↑ Neisseria, Alloprevotella, Aggregatibacter, Porphyromonoas endodontalis, Streptococcus mitis in GC ↓ Sphingobium yanoikuyae in GC |
Park26 | Case-control | 55 GC, 19 IM, 62 chronic gastritis patients | Korea | Gastric biopsies from antrum | 16S rRNA gene sequencing using Illumina MiSeq | Relative bacterial abundance | ↑ Rhizobiales in IM compared to gastritis ↑ Cyanobacteria in H. pylori negative chronic gastritis patients |
GC, gastric cancer; IM, intestinal metaplasia; AG, atrophic gastritis.